Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The aim of the present study was to assess the cost of atopic eczema to the patient and to the health service. Patients were recruited from a therapy evaluation study for the secondary prevention of atopic eczema. According to our calculations, the cost of atopic eczema to society is DM 4827 per annum per patient, and the cost to the individual patient is DM 468. On the basis of an estimated 1.5 million patients in the German population, the total cost of corticosteroids alone is approximately DM 450 million, and the annual cost to society including other costs (doctors' fees, hospitals) is DM 7 billion. It remains to be confirmed whether our findings can be verified in larger groups. Because of the current cost explosion in the provision of the health services, it is especially important to consider the financial aspect of diseases and their treatment.


Journal article


Journal of Dermatological Treatment

Publication Date